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  EVIDENCE-BASED ANSWER 
No studies have demonstrated that cessation of breastfeeding in jaundiced infants improves clinical outcomes, 
although this has only been studied in term infants. Temporarily disrupting or supplementing breastfeeding in 
jaundiced infants is associated with premature cessation of breastfeeding (strength of recommendation [SOR]: 
B, based on a nonrandomized, nonblinded trial). Jaundiced breastfed term infants have no significant 
difference in length of phototherapy, and no increased rate of exchange transfusion or kernicterus compared 
with jaundiced bottle-fed term infants (SOR: B, based on a low-quality randomized controlled trial and a 
prospective cohort study). In light of the association of breastfeeding with improved health outcomes,1 mothers 
of jaundiced term infants should be encouraged to continue breastfeed. 
  EVIDENCE SUMMARY 
Although breastfeeding jaundice is a benign entity, other risk factors for bilirubin toxicity can coexist. These 
include jaundice in the first day of life, previously jaundiced sibling, early gestational age, significant bruising or 
cephalohematoma, Rh and ABO incompatibility, G6PD deficiency, and elevated hour-specific serum or 
transcutaneous bilirubin levels.2,3 
Late initiation of breastfeeding and temporary cessation or supplementation of breastfeeding increase the 
likelihood of premature breastfeeding termination.4 In a prospective cohort study of 138 breastfed term infants, 
more than twice as many mothers of jaundiced infants had stopped breastfeeding compared with mothers of 
nonjaundiced infants, at the end of 1 month (42% vs 19%; number needed to harm [NNH]=4; P<.01). In 
addition, 64% of the jaundiced infants whose nursing had been interrupted in the hospital had stopped 
breastfeeding by 1 month, compared with only 36% of those who had no interruption (relative risk [RR]=1.8; 
P<.05; NNH=4).5 
Whether they require phototherapy or not, continuing breastfeeding in jaundiced infants is not associated with 
adverse outcomes. In a prospective cohort study of 163 healthy, jaundiced newborn infants undergoing 
phototherapy (total serum bilirubin ≥17 mg/dL), exclusively breastfed infants had slower response to 
phototherapy in the first 24 hours than formulafed or formula-supplemented infants (bilirubin decreases of 
17.1% vs 18% and 22.9%, respectively; P=.03). However, there were no significant differences in total length 
of phototherapy among the 3 groups (phototherapy time of 64.5 hours vs 54.1 hours and 54.9 hours, 
respectively; P=.06).6 
In a randomized, nonblinded clinical trial, 125 jaundiced breastfed newborns (total serum bilirubin level of 
≥17mg/dL) were assigned to 4 treatment groups: (1) continue breastfeeding and observe; (2) discontinue 
breastfeeding, substitute with formula; (3) discontinue breastfeeding, substitute with formula, and administer 
phototherapy; and (4) continue breastfeeding, administer phototherapy. The study did not find a clinically 
significant difference in serum bilirubin reduction to normal levels at 48 hours between breastfed and bottle-fed 
groups undergoing phototherapy (RR=1.07; 95% confidence interval [CI], 0.6–1.92; P=.818), or between 
breastfed and bottle-fed groups who did not have phototherapy (RR not calculated; P=.051). No patient 
required exchange transfusion, and in no case did total serum bilirubin exceed 23 mg/dL.7 
  RECOMMENDATIONS FROM OTHERS 
The American Academy of Pediatrics (AAP) has reported numerous positive health outcomes in infants who 
are breastfed, including reduced incidence and less-severe diarrhea; lower incidence of otitis media, fewer 
respiratory infections; and lower incidence of bacteremia, bacterial meningitis, botulism, urinary tract infections 
and necrotizing enterocolitis. 
In addition, they reported association between breastfeeding and enhanced cognitive development; and 
decreased incidence in sudden infant death syndrome, insulin-dependent diabetes mellitus, atopy, and 
inflammatory bowel diseases. They noted maternal benefits including less postpartum bleeding and lactational 
amenorrhea; more rapid postpartum weight loss and improved bone remineralization; and reduced risk of 
ovarian cancer and premenopausal breast cancer.1 
The AAP discourages the termination of breastfeeding in jaundiced healthy term newborns and encourages 
continued and frequent breastfeeding (at least 8 to 10 times every 24 hours), encouraging physician’s 
judgment and patient’s preferences to determine final treatment options for breastfeeding jaundiced 
newborns.2 
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Reassure mothers to prevent cessation of 
breastfeeding 
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Breast milk jaundice occurs with such frequency that careful anticipatory guidance 
provided during later pregnancy is a physician’s time well spent. Education of both 
prospective parents and other potentially influential family members in attendance during 
a prenatal visit is wise. 
In practice, I have found the greatest challenge is providing enough support and 
encouragement for the nursing mother to counterbalance the suggestions of well-meaning 
friends and family that she stop breastfeeding altogether. The only treatment generally 
required is an increase in the frequency of feedings and up to 12 weeks time for all to 
resolve. 
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